We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BON
4026
Bon Natural Life
BON
$9.1M
$12K ﹤0.01%
+44
New +$14.7K
FRSX
4027
Foresight Autonomous Holdings
FRSX
$3.76M
$12K ﹤0.01%
228
-1,357
-86% -$96.5K
ALLR
4028
Allarity Therapeutics
ALLR
$18.5M
0
CRBP icon
4029
Corbus Pharmaceuticals
CRBP
$165M
$11K ﹤0.01%
3,423
-22,928
-87% -$88.2K
XMAX
4030
XMAX Inc
XMAX
$530M
$11K ﹤0.01%
4,849
-240
-5% -$684
SOPA
4031
DELISTED
Society Pass
SOPA
$11K ﹤0.01%
+760
New +$16.6K
VTGN icon
4032
VistaGen Therapeutics
VTGN
$9.98M
$11K ﹤0.01%
3,493
-121,919
-97% -$459K
EGLX
4033
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$11K ﹤0.01%
+19,600
New +$13K
ACGN
4034
DELISTED
Aceragen Inc
ACGN
$11K ﹤0.01%
1,865
+22
+1% +$132
REED
4035
DELISTED
Reeds, Inc. Common Stock
REED
$11K ﹤0.01%
3,196
+310
+11% +$1.74K
PRFX icon
4036
PRF Technologies Ltd
PRFX
$3.01M
$10K ﹤0.01%
20
-1
-5% -$636
CNTN
4037
Canton Strategic Holdings
CNTN
$149M
$10K ﹤0.01%
+70
New +$13.9K
BLCM
4038
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$10K ﹤0.01%
13,700
VYNT
4039
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$10K ﹤0.01%
14,320
+10,160
+244% +$16.5K
IMDX
4040
Insight Molecular Diagnostics
IMDX
$141M
$9K ﹤0.01%
+1,410
New +$15.5K
RNAZ icon
4041
TransCode Therapeutics
RNAZ
$5.25M
0
PLXP
4042
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$9K ﹤0.01%
+54,500
New +$22.8K
ASPU
4043
DELISTED
ASPEN GROUP, INC.
ASPU
$9K ﹤0.01%
27,600
-12,450
-31% -$4.51K
CUEN
4044
DELISTED
Cuentas Inc. Common Stock
CUEN
$9K ﹤0.01%
+4,015
New +$17.1K
HSTO
4045
DELISTED
Histogen Inc. Common Stock
HSTO
$9K ﹤0.01%
+10,600
New +$11.8K
VRAX icon
4046
Virax Biolabs
VRAX
$2.34M
$8K ﹤0.01%
+46
New +$16.3K
LKCO
4047
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$8K ﹤0.01%
208
+28
+16% +$1.17K
AWH
4048
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$8K ﹤0.01%
1,700
-174
-9% -$951
VISL
4049
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$8K ﹤0.01%
+720
New +$5.91K
EFOI icon
4050
Energy Focus
EFOI
$18M
$7K ﹤0.01%
3,171
-10,720
-77% -$29.4K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.